Detail of the clinical trial

Title of the trial A pivotal, randomised study of lonafarnib (SCH 66336) versus placebo in the treatment of subjects with myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML) who are platelet transfusion dependent, with or without anemia
EudraCT number 2004-004685-32
Protocol number P02978
Sponsor Schering-Plough Research Institute, Kenilworth, NJ, United States of America
Indications Hemato-oncology
Diagnosis myelodysplastic syndrome or chronic myelomonocytic leukemia
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2005
Date of approval by Institute (SÚKL) 04.08.2005
Date of approval by EC
Date of initiation CT in ČR 29.05.2006
Date of ending CT in ČR 17.06.2008
Notice
Sites Ústav hematologie a krevní transfuze, U Nemocnice 1, 128 20 PRAHA 2
Hematoonkologické oddělení, Fakultní nemocnice Olomouc, I. P. Pavlova 6, 775 20 OLOMOUC

‹‹ Back to list